Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3751_Библиотеки_им_академика_М_И_Перельмана
.pdf
extracranialvasculature
fibromusculardysplasia(FMD),49–50,50
traumaticcervicalvascularinjury,51,52–54
femoralaccess,51
radialaccess
micropuncturetechnique,54–55
peripheralarterialaccesstechnique,51
transradialaccess,51
transradialcoronaryangiography,51–53
revascularization
AsymptomaticCarotidEmboliStudy(ACES),45
asymptomaticextracranialcarotidstenosis,46
benefits,45
carotidarterystenting(CAS),48
carotidendarterectomy(CEA),47–48
CarotidRevascularizationEndarterectomyversusStentingTrial(CREST),45–47
EndarterectomyforAsymptomaticCarotidStenosisStudy,45–46
EuropeanCarotidSurgeryTrial(ECST),47
evidence,44–45
extracranialsymptomaticvertebralarterydisease,49
intracraniallargearteryatherosclerosisdisease,48–49
medicaltherapy,46
NorthAmericanSymptomaticCarotidEndarterectomyTrial(NASCET),46
StentingandAngioplastywithProtectioninPatientswithHighRiskofEndarterectomy(SAPPHIRE)trial,45
timingof,47
Warfarin-AspirinSymptomaticIntracranialDiseaseStudy(WASID),49
statutoryqualityassurancedatabase,56
symptomatic,43
Carotidarterystenting(CAS),11,41,48
Carotidendarterectomy(CEA),11,41,47–48
CarotidRevascularizationEndarterectomyversusStentingTrial(CREST),45–47
CASSeeCarotidarterystenting(CAS)
Catheter-baseddenervation,189–190
Catheter-basedrevascularizationstrategies,244
Catheter-directedembolectomy,352–353
evidence,352
rheolyticthrombectomy,352
rotationalthrombectomy,353
suctionembolectomy,353
thrombusfragmentation,352
Catheter-directedtherapy,369–370
Catheterdirectedthrombolysis(CDT),12,304,353
CCDSeeCharge-coupleddevice(CCD)
CCPSSeeCoveredCheathamPlatinumstent(CCPS)
https://t.me/med1917

CDTSeeCatheterdirectedthrombolysis(CDT)
CEASeeCarotidendarterectomy(CEA)
CentersforDiseaseControlandPrevention,98
Charge-coupleddevice(CCD),5,6
CHARISMAtrial,320
CheathamPlatinum(CP)Stent,85
Chronicdeepveinthrombosis,372–373
Chroniclimbischemia(CLI)
belowkneerevascularization
endovascularrevascularization,235
managementalgorithm,235,236
RutherfordandFontaine’sclassification,234,235t
symptomsandclinicalmanifestations,234
definition,234
Chronicthromboembolicpulmonaryhypertension(CTEPH)
diagnosis,361
prevalence,360–361
pulmonaryendarterectomy,361–362
Chronictotalocclusions(CTOs),238,290
CI-AKISeeContrast-inducedacutekidneyinjury(CI-AKI)
Cilostazol,322–323
CircleofWillis(COW),19
ClariVeindevice,400
Claudication
aortoiliacocclusivedisease(AIOD),200
peripheralarterialdisease(PAD),215
CLISeeCriticallimbischemia(CLI)
CliRpathExcimerLaserSystemtoEnlargeLumenOpenings(CELLO)trial,279
CO2angiography,11
CoarctationoftheaortaSeeAorticcoarctation
CoarctationoftheAortaStentTrial(COAST),87
COASTSeeCoarctationoftheAortaStentTrial(COAST)
Cockettsyndrome,381
Collateralcirculations,19–20
ColorDopplerultrasound(CDUS),383
Commonfemoraldisease,314
Compartmentsyndrome,10
COMPASStrial,321
COMPLIANCE360trial,283
Computedtomographicangiography(CTA)
carotidarterystenosis,36,37–38,43,44
Computedtomography(CT),20
ascendingaortaandaorticarch,111–112
May-Thurnersyndrome(MTS),384
https://t.me/med1917

Computedtomographicangiography(CTA),20
aortoiliacocclusivedisease(AIOD),201
descendingaorta,endovascularrepair,141
renovasculardisease,181
subclavianarterystenosis/interventions,68
Concomitantiliacdisease
commonfemoralarterialdisease,312–313
andinfrainguinaldisease,313
Concurrentcommonfemoraldisease,203
Congenitalheartlesions,77
Contrast
agents,molecularstructure,9,9
commonadverseeffects,10
lesscommonadverseeffects,10
modernradiocontrastagents,9
venography,384
Contrast-inducedacutekidneyinjury(CI-AKI)
commonadverseeffects,10
riskfactors,10
CookArchBranchdevice,115
CORALtrialSeeCardiovascularOutcomesinRenalAtheroscleroticLesions(CORAL)trial
Coronarystealphenomenon,67,67
CoveredCheathamPlatinumstent(CCPS),87
CoveredCPStent,85
CoveredVersusBalloon-ExpandableStentTrial(COBEST),263
COWSeeCircleofWillis(COW)
CPstentSeeCheathamPlatinum(CP)Stent
CRESTSeeCarotidRevascularizationEndarterectomyversusStentingTrial(CREST)
Criticallimbischemia(CLI)
aortoiliacocclusivedisease(AIOD),200
excimerlaseratherectomy(ELA),277–278
peripheralarterialdisease(PAD),215
CTSeeComputedtomography(CT)
CTASeeComputedtomographicangiography(CTA)
CTEPHSeeChronicthromboembolicpulmonaryhypertension(CTEPH)
CTOsSeeChronictotalocclusions(CTOs)
Cuttingballoonangioplasty
complications,163–164
long-segmentstenoses,163
procedure,164
Cyanoacrylateglue(CAG)
application,402–403,403
vs.endovenouslaserablation(EVLA),404
eSCOPEStudy,403
https://t.me/med1917

D
DASeeDirectionalatherectomy(DA)
DCBSeeDrug-coatedballoons(DCB)
Deepveinthrombosis(DVT),12,381SeeAlsoVenousthromboembolism(VTE)
DEFINITIVELEtrial,284
Descendingaorta,endovascularrepair
anatomy,126
complications
ataccesssites,148
endoleaks,146–147,147t
extremityischemia,148
graftmigration,149
perioperativemortalityandmorbidity,146
postimplantationsyndrome,148
secondaryintervention,149
spinalcordischemia,147
stroke,148
survivalandoutcomes,148–149
visceralischemia,148
descendingthoracicaorticaneurysms(DTAs),126
endograftstructure
deliverysystem,129
extensions,130
maindevice,130
transfemoralapproach,129
ZenithAlphathoracicstentgraft,129,130
E-Vitastentgraftsystem,140
landingzones,126–127,127
placementtechnique
deployment,145–146
endoleaks,146
postoperativeimaging,146
preclosetechnique,145
preoperativepreparation
antibiotics,144
cerebrospinalfluiddrainage,144–145
renalinjury,144
preproceduralplanning
archvesselbypass,142–143
computedtomograpicangiography(CTA),141
fenestratedendovascularaneurysmrepair(FEVAR),143
graftselection,141–142
landingzones,141,142
magneticresonanceangiography(MRA),141
https://t.me/med1917

visceralbypass,143,144
spinalperfusion,127
StreamlinerMultilayerFlowModulator(SMFM),140,140
TAArgetthoracicstent-graft,136,139
thoracicendovascularaorticrepair(TEVAR),126SeeAlsoThoracicendovascularaorticrepair(TEVAR)
Descendingthoracicaorticaneurysms(DTAs),126,128
DESSeeDrug-elutingstents(DES)
DESTINYtrial,248–249
Diamondback360,282,283
Diatrizoate,9
Diffusion-weightedimaging(DWI),20
Digitalimagingsystems,9
Digitalsubtractionangiography(DSA),39,40–41,43,44
Directionalatherectomy(DA),284t
DEFINITIVELEtrial,284
MedtronicSilverHawkandTurboHawk,284,285
moderate-to-severevesselcalcification,284–285
Directmethod,endoluminalstenting,185
Distalembolicprotection
filterdevice/distalballoon,56–57,57–59
transfemoralcarotidangioplasty,57,59t
Distalinfrainguinaldisease,314
Distallowerextremityaccesssitehemorrhage,328
DRASTICtrialSeeDutchRenalArteryStenosisInterventionCooperativeStudy(DRASTIC)trial
Drug-coatedballoons(DCB),223–224
belowkneedisease,251–252
revascularization,240
drugsused,245–246
elements,246,247
forfemoropoplitealdisease
advantages,250
FEMPACtrial,250
IN.PACTSFAtrial,250–251,253t
PACIFIERtrial,250,251–252
stentrestenosis,252–253
targetlesionrevascularization(TLR),254,254
Drug-elutingstents(DES),223,225–226
belowkneedisease
DESTINY,248–249
limb-savingstrategy,248
PARADISE,249
YUKON-BTKtrial,248
drugsused,245–246
dualantiplatelettherapy,250
https://t.me/med1917

elements,246
forfemoropoplitealdisease
Everolimus-elutingstent,247
SIROCCOIandII,246–247
ZilverPTX,247,248,249t
focalandshortlesions,249
inflammatorythromboticreactions,225
long-termresults,249
self-expandingstents
first-generation,269
in-development,270–271
paclitaxelperipheral,270,271t
targetlesionrevascularization(TLR),254,254
ZilverPTX,226
DSASeeDigitalsubtractionangiography(DSA)
Duplexultrasound(DUS),34,35,36
acutelimbischemia(ALI),301
aortoiliacocclusivedisease(AIOD),201
May-Thurnersyndrome(MTS),383
renovasculardisease,180–181
DutchRenalArteryStenosisInterventionCooperativeStudy(DRASTIC)trial,187
DWISeeDiffusion-weightedimaging(DWI)
E
ECASSSeeEuropeanCooperativeAcuteStrokeStudy(ECASS)
ECSTSeeEuropeanCarotidSurgeryTrial(ECST)
ELASeeExcimerlaseratherectomy(ELA)
Elephanttrunkprocedure,106
Embolicprotectiondevices(EPDs)
cerebral,61
complications,61
distal
filterdevice/distalballoon,56–57,57–59
transfemoralcarotidangioplasty,57,59t
proximal,59–60,60,61t
transcarotidcarotidarteryrevascularization(TCAR),60–61,61,62t
types,56
EMMAstudySeeEssaiMulticentriqueMedicamentsvsAngioplastie(EMMA)study
Endarterectomy,312
EndarterectomyforAsymptomaticCarotidStenosisStudy,45–46
Endarterectomyversusangioplastyinpatientswithsymptomaticseverecarotidstenosis(EVA-3S)trial,55
Endoluminalstenting,renalrevascularization
directmethod,185
no-touchtechnique,184–185
https://t.me/med1917

procedure,185–186,186
renalarterystentrestenosis,184
Endothemalheat–inducedthrombosis(EHIT),399,400
Endovascularaneurysmrepair(EVAR),12
EndovascularAtherectomySafetyandEffectivenessStudy(EASE)trial,286
Endovascularintervention,2
EndovasculartreatmentforSmallCoreandAnteriorcirculationProximalocclusionwithEmphasis(ESCAPE)trial,23
Endovenouslaserablation(EVLA),397
complications,398
vs.cyanoacrylateglue(CAG),404
vs.radiofrequencyablation,404
treatment,398
EPDsSeeEmbolicprotectiondevices(EPDs)
Erectiledysfunction,200
eSCOPEStudy,403
EssaiMulticentriqueMedicamentsvsAngioplastie(EMMA)study,187
EuropeanCarotidSurgeryTrial(ECST),47
EuropeanCollaboratorsonStent/GraftTechniquesforAorticAneurysmRepair(EUROSTAR)registry,145
EuropeanCooperativeAcuteStrokeStudy(ECASS),21
EUROSTARregistrySeeEuropeanCollaboratorsonStent/GraftTechniquesforAorticAneurysmRepair(EUROSTAR)registry
ev3IntraStentLDMaxstent,86–87
EVARSeeEndovascularaneurysmrepair(EVAR)
Everolimus-elutingstent,247
E-vitaopenandtheE-vitaplus,117,117–118
E-Vitastentgraftsystem,140
EVLASeeEndovenouslaserablation(EVLA)
Excimerlaseratherectomy(ELA)
claudicants,278–279
in-stentrestenosis,279–280,279t
LaserAngioplastyinCriticalLimbIschemia(LACI)Belgiumtrial,278
systemmechanics,277–278
turbo-elitelaseratherectomycatheter,277,277
EXCImerLaserRandomizedControlledStudyforTreatmentofFemoropopliTEalIn-StentRestenosis(EXCITE-ISR)trial,279
ExtendingtheTimeforThrombolysisinEmergencyNeurologicalDeficits-Intra-Arterial(EXTEND-IA)trial,24
Extracardiacvascularanomalies,77
Extremityischemia,148
F
FalseaneurysmsSeePseudoaneurysms(PSAs)
Femoralaccesssitebleeding,326–327
Femoropolitealintervention,217–218,218t
Femoropoplitealdisease
drug-coatedballoons(DCB)
advantages,250
https://t.me/med1917

FEMPACtrial,250
IN.PACTSFAtrial,250–251,253t
PACIFIERtrial,250,251–252
drug-elutingstents(DES)
Everolimus-elutingstent,247
SIROCCOIandII,246–247
ZilverPTX,247,248,249t
Femoropopliteallesions,218,218t
FEMPACtrial,250
Fenestratedendovascularaneurysmrepair(FEVAR),143
FEVARSeeFenestratedendovascularaneurysmrepair(FEVAR)
Fibromusculardysplasia,(FMD),49–50,50
nonatheroscleroticrenovasculardisease,178–179,179–180
Filterembolicprotectiondevice,56–57,57–59
Flatpanelsystem,5,6
Fluoroscopy,2,4–5
FMDSeeFibromusculardysplasia(FMD)
Frozenelephanttrunkprocedure,117
G
Guideline-directedmedicaltherapy(GDMT),318
Guidewiretechnique,4
H
Hematoma
brachialhemorrhage,328
distallowerextremityaccesssitehemorrhage,328
femoralaccesssitebleeding,326–327
radialhemorrhage,328
retroperitoneal(RP)hemorrhage,327–328,328
riskfactors,326
ultrasound,326,327
Hemorrhagicstroke,18
Heparin,320
High-pressureballoonangioplasty,162–163
HOPEtrial,322
Hybridlowerextremityrevascularization
aortoiliacandinfrainguinaldisease,312
benefits,314,314t
bilateraliliacdisease,severe,313
commonfemoraldisease,314
concomitantiliacdisease
commonfemoralarterialdisease,312–313
andinfrainguinaldisease,313
https://t.me/med1917

distalinfrainguinaldisease,314
drugs,312
infrainguinalmultileveldisease,313
outcomes,314
preprocedureplanning,312
Hyperlipidemia,321
Hypertension
aorticcoarctation,76–77
renovasculardisease,178
I
IDDVTSeeIsolateddistaldeepveinthrombosis(IDDVT)
Iliacveincompressionsyndrome,380–381
acutedeepveinthrombosis,388–389
withpostthromboticsyndrome,390
withsymptomaticnonthromboticchronicvenousinsufficiency,390
Iliacveinthrombosis,380
Imageintensifier,5,6
IMStrialSeeInterventionalManagementofStroke(IMS)trial
Infectioncontrol,limbsalvage
antibiotics,338–339
biomechanicalexamination,339
osteomyelitis,339–340
riskfactors,338
Informedconsent,13
Infrainguinalmultileveldisease,313
Innominateangiography,68–69,69
IN.PACTSFAtrial,250–251,253t
INSTEADtrialSeeInvestigationofStentgraftsinpatientswithtypeBAorticDissection(INSTEAD)trial
InternationalConsensusStatementonPreventionandTreatmentofVenousThromboembolism,372
InternationalRegistryofAcuteAorticDissection(IRAD),129
InterventionalManagementofStroke(IMS)trial,21–22
Intramuralhematoma(IMH),107,107
Intravascularimagingtechniques,9
Intravenoustissueplasminogenactivator(IVtPA),20–21
Intravenous(IV)unfractionatedheparin,354
Invasiveangiography,201–202
Invasivedigitalsubtractionangiography,68
Invasiverenalveinsampling,181
InvestigationofStentgraftsinpatientswithtypeBAorticDissection(INSTEAD)trial,129
Invivoimaging,limitationsandadvantages,3–4
Iodine-inducedhyperthyroidism,10
Iodinemumps,10
Iohexol,9
https://t.me/med1917

Ioniccontrasts,9
Ionizingradiation
deoxyribonucleicacid(DNA),5
operators,6
patients,5–6
proceduralX-raydosage,6
Ioxaglate,9
IRADSeeInternationalRegistryofAcuteAorticDissection(IRAD)
Ischemiccoreterritory,19–20
Ischemicstroke,18
causes,41
intravenoustissueplasminogenactivator(IVtPA),21
Isolateddistaldeepveinthrombosis(IDDVT)
AmericanCollegeofChestPhysiciansGuidelines,372
clinicalhistory,371
InternationalConsensusStatementonPreventionandTreatmentofVenousThromboembolism,372
management,371
recurrencerisk,371
Iso-osmolardimeriodixanol(Visipaque),4,9
IVtPASeeIntravenoustissueplasminogenactivator(IVtPA)
J
JetstreamXC,280,281
JupiterTrial,374
L
Largevesselocclusions(LVOs),18
LaserAngioplastyinCriticalLimbIschemia(LACI)Belgiumtrial,278
Limbsalvage
advancedwoundhealing
acuteinflammatoryphase,340
chokevessels,342
extracellularmatrix,340
maturationphase,340
noninvasivevascularstudies,parameters,340
proliferativephase,340
rhomboidtranspositionalflap,342,342
splitthicknessskingrafting(STSG),341,341
infectioncontrol
antibiotics,338–339
biomechanicalexamination,339
osteomyelitis,339–340
riskfactors,338
peripheralneuropathy,338
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
